The Minapild Study Project: New tools to identify causes and prevent Interstitial Lung Diseases

M. Catinon (Villeurbanne, France), J. Mornex (Lyon, France), V. Cottin (Lyon, France), R. Elisabeth (Villeurbanne, France), F. Thivolet (Bron, France), S. Marchand-Adam (Tours, France), S. Jouneau (Rennes, France), M. Kerjouan (Rennes, France), A. Sale (Rennes, France), D. Israel-Biet (Paris, France), J. Vergnon (Saint-Etienne, France), N. Freymond (Lyon, France), S. Cofta (Poznan, Poland), J. Müller-Quernheim (Freiburg, Germany), G. Fouilloux (Villeurbanne, France), V. Massardier (Villeurbanne, France), A. Trunfio-Sfarghiu (Villeurbanne, France), Y. Song (Beijing, China), A. Auroux (Villeurbanne, France), M. Veltkamp (Nieuwegein, Netherlands), M. Vincent (Villeurbanne, France)

Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Session: Sarcoidosis: a multifaceted disease that is difficult to manage
Session type: Thematic Poster
Number: 1392
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Catinon (Villeurbanne, France), J. Mornex (Lyon, France), V. Cottin (Lyon, France), R. Elisabeth (Villeurbanne, France), F. Thivolet (Bron, France), S. Marchand-Adam (Tours, France), S. Jouneau (Rennes, France), M. Kerjouan (Rennes, France), A. Sale (Rennes, France), D. Israel-Biet (Paris, France), J. Vergnon (Saint-Etienne, France), N. Freymond (Lyon, France), S. Cofta (Poznan, Poland), J. Müller-Quernheim (Freiburg, Germany), G. Fouilloux (Villeurbanne, France), V. Massardier (Villeurbanne, France), A. Trunfio-Sfarghiu (Villeurbanne, France), Y. Song (Beijing, China), A. Auroux (Villeurbanne, France), M. Veltkamp (Nieuwegein, Netherlands), M. Vincent (Villeurbanne, France). The Minapild Study Project: New tools to identify causes and prevent Interstitial Lung Diseases. 1392

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018




Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used
Source: International Congress 2017 – Rare diseases
Year: 2017

Multicenter Registry of Interstitial Lung Diseases in Brazil
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration
Source: Eur Respir J, 53 (3) 1900217; 10.1183/13993003.00217-2019
Year: 2019



DANILDA – The First Danish National Interstitial Lung Disease Registry
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019

Characteristics of Connective Tissue Diseases Associated Interstitial Lung Diseases - A Single Centre Study in Sri Lanka
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021

Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly
Source: ERJ Open Res, 6 (4) 00143-2020; 10.1183/23120541.00143-2020
Year: 2020



Implementation of FAST strategy in the National Center for Tuberculosis and Lung Diseases (NCTLD) in Georgia
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018




Singing for Lung Health: Evaluation of the British Lung Foundation programme.
Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques
Year: 2018

Impact of a Bayesian approach on the diagnosis of Interstitial Lung Diseases
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019


Case Series of COVID-19 Disease in Pediatric Chronic Lung Diseases
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021


The Disease Burden of Bronchiectasis in Korea: A National Database Study
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019


The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration
Source: Eur Respir J, 52 (6) 1801855; 10.1183/13993003.01855-2018
Year: 2018



Update on CADSET (Chronic Airway Disease Early Stratification) Clinical Research Collaboration
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020


Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




GPs Meet Rare Lung Disorders Task Force factsheet: childhood interstitial lung disease
Source: Breathe 2014; 10:173-175
Year: 2014



Hospitalisation pattern in Interstitial Lung Diseases: a claims data study
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018